| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | creatine kinase activity | 2.32e-08 | 6 | 127 | 4 | GO:0004111 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, nitrogenous group as acceptor | 1.07e-07 | 8 | 127 | 4 | GO:0016775 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B SLC25A24 NCALD CABP5 PLA2G2E RYR1 RYR2 ITPR3 ITSN2 LRP1 UNC13C CALML4 PLCH1 ADGRE1 UNC13A CDH16 | 2.21e-05 | 749 | 127 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.84e-05 | 28 | 127 | 4 | GO:0001972 | |
| GeneOntologyMolecularFunction | BRE binding | 4.01e-05 | 2 | 127 | 2 | GO:0042835 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 4.01e-05 | 2 | 127 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 4.01e-05 | 2 | 127 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 5.43e-05 | 64 | 127 | 5 | GO:0036002 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 7.01e-05 | 35 | 127 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.13e-04 | 230 | 127 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | diacylglycerol binding | 1.32e-04 | 16 | 127 | 3 | GO:0019992 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.91e-04 | 18 | 127 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | mediator complex binding | 2.39e-04 | 4 | 127 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 2.39e-04 | 4 | 127 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | retinoid binding | 2.45e-04 | 48 | 127 | 4 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 2.65e-04 | 49 | 127 | 4 | GO:0019840 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ATP7A RTEL1 MYO9B SEPTIN9 PEX1 CCT4 ARL8A RAB6B RGS7 SEPTIN6 RAB38 RAB24 SMC3 SEPTIN11 | 4.19e-04 | 775 | 127 | 14 | GO:0017111 |
| GeneOntologyMolecularFunction | cyclase activity | 4.61e-04 | 24 | 127 | 3 | GO:0009975 | |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 4.61e-04 | 24 | 127 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | phosphorus-oxygen lyase activity | 5.22e-04 | 25 | 127 | 3 | GO:0016849 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 5.92e-04 | 6 | 127 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 6.09e-04 | 107 | 127 | 5 | GO:0033293 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 8.29e-04 | 66 | 127 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ATP7A RTEL1 MYO9B SEPTIN9 PEX1 CCT4 ARL8A RAB6B RGS7 SEPTIN6 RAB38 RAB24 SMC3 SEPTIN11 | 9.12e-04 | 839 | 127 | 14 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ATP7A RTEL1 MYO9B SEPTIN9 PEX1 CCT4 ARL8A RAB6B RGS7 SEPTIN6 RAB38 RAB24 SMC3 SEPTIN11 | 9.22e-04 | 840 | 127 | 14 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ATP7A RTEL1 MYO9B SEPTIN9 PEX1 CCT4 ARL8A RAB6B RGS7 SEPTIN6 RAB38 RAB24 SMC3 SEPTIN11 | 9.22e-04 | 840 | 127 | 14 | GO:0016818 |
| GeneOntologyMolecularFunction | fatty acid binding | 9.80e-04 | 69 | 127 | 4 | GO:0005504 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 9.92e-04 | 31 | 127 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.19e-03 | 33 | 127 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.41e-03 | 129 | 127 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | GTPase activity | 1.54e-03 | 341 | 127 | 8 | GO:0003924 | |
| GeneOntologyMolecularFunction | lipid binding | UNC13B UGT1A10 UGT1A8 UGT1A7 ICA1 PEX1 UGT1A9 PLA2G2E CHMP2A SNX13 ITPR3 CKMT2 UNC13C UNC13A HDLBP | 1.54e-03 | 988 | 127 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | enzyme regulator activity | WASL MYO9B UGT1A10 UGT1A8 UGT1A7 IQSEC2 DOCK10 UGT1A9 PSMD2 RGS7 PREX2 ITIH3 INKA2 PPP4R4 ITSN2 CALML4 HERC1 DNMBP SERPIND1 | 1.57e-03 | 1418 | 127 | 19 | GO:0030234 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.59e-03 | 343 | 127 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | SLC25A27 MYO9B UGT1A10 UGT1A8 UGT1A7 UGT1A9 XDH CHUK MIGA2 MKLN1 AADAT TP53BP2 LRRFIP1 | 2.08e-03 | 815 | 127 | 13 | GO:0042803 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.81e-03 | 151 | 127 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.93e-03 | 465 | 127 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 3.12e-03 | 46 | 127 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.47e-03 | 14 | 127 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 3.63e-03 | 231 | 127 | 6 | GO:0005085 | |
| GeneOntologyMolecularFunction | beta-tubulin binding | 3.74e-03 | 49 | 127 | 3 | GO:0048487 | |
| GeneOntologyMolecularFunction | GTP binding | 3.91e-03 | 397 | 127 | 8 | GO:0005525 | |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 4.42e-03 | 52 | 127 | 3 | GO:0043014 | |
| GeneOntologyMolecularFunction | small GTPase binding | 4.49e-03 | 321 | 127 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | Arp2/3 complex binding | 4.54e-03 | 16 | 127 | 2 | GO:0071933 | |
| GeneOntologyMolecularFunction | snRNP binding | 4.54e-03 | 16 | 127 | 2 | GO:0070990 | |
| GeneOntologyMolecularFunction | mRNA regulatory element binding translation repressor activity | 5.13e-03 | 17 | 127 | 2 | GO:0000900 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 5.15e-03 | 507 | 127 | 9 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 5.15e-03 | 507 | 127 | 9 | GO:0030695 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.56e-03 | 334 | 127 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | organic acid binding | 5.74e-03 | 254 | 127 | 6 | GO:0043177 | |
| GeneOntologyMolecularFunction | adenylate cyclase activity | 5.74e-03 | 18 | 127 | 2 | GO:0004016 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1D SLC25A27 CACNA1S SCN11A ATP7A RYR1 RYR2 ITPR3 SCN7A KCNQ3 | 6.78e-03 | 627 | 127 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | 7.07e-03 | 439 | 127 | 8 | GO:0032561 | |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | 7.07e-03 | 439 | 127 | 8 | GO:0019001 | |
| GeneOntologyMolecularFunction | ubiquitin-modified protein reader activity | 7.07e-03 | 20 | 127 | 2 | GO:0140036 | |
| GeneOntologyBiologicalProcess | phosphocreatine metabolic process | 6.82e-09 | 5 | 127 | 4 | GO:0006603 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 6.82e-09 | 5 | 127 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | phosphagen biosynthetic process | 6.82e-09 | 5 | 127 | 4 | GO:0042396 | |
| GeneOntologyBiologicalProcess | phosphocreatine biosynthetic process | 6.82e-09 | 5 | 127 | 4 | GO:0046314 | |
| GeneOntologyBiologicalProcess | phosphagen metabolic process | 6.82e-09 | 5 | 127 | 4 | GO:0006599 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 2.04e-08 | 6 | 127 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 2.04e-08 | 6 | 127 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 2.04e-08 | 6 | 127 | 4 | GO:0051552 | |
| GeneOntologyBiologicalProcess | spliceosomal complex assembly | 1.77e-07 | 99 | 127 | 8 | GO:0000245 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.80e-07 | 10 | 127 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.80e-07 | 10 | 127 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | mRNA splice site recognition | 7.81e-07 | 52 | 127 | 6 | GO:0006376 | |
| GeneOntologyBiologicalProcess | dense core granule priming | 9.08e-07 | 4 | 127 | 3 | GO:0061789 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 9.39e-07 | 13 | 127 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 1.67e-06 | 59 | 127 | 6 | GO:0000381 | |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 2.26e-06 | 5 | 127 | 3 | GO:0052696 | |
| GeneOntologyBiologicalProcess | synaptic vesicle docking | 3.07e-06 | 17 | 127 | 4 | GO:0016081 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 3.55e-06 | 67 | 127 | 6 | GO:0019748 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | 7.56e-06 | 21 | 127 | 4 | GO:0052695 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 7.56e-06 | 21 | 127 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 9.31e-06 | 79 | 127 | 6 | GO:0000380 | |
| GeneOntologyBiologicalProcess | calcium ion-regulated exocytosis of neurotransmitter | 1.57e-05 | 25 | 127 | 4 | GO:0048791 | |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | 1.84e-05 | 26 | 127 | 4 | GO:0019585 | |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | 1.84e-05 | 26 | 127 | 4 | GO:0006063 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | UNC13B CACNA1D SLC25A27 CACNA1S PDE3B ATP7A ACACB ADCY5 RYR1 RYR2 ITPR3 CKB RAB38 NOX1 SCN7A LRP1 PLCH1 | 2.34e-05 | 866 | 127 | 17 | GO:0055082 |
| GeneOntologyBiologicalProcess | pigment metabolic process | 2.53e-05 | 94 | 127 | 6 | GO:0042440 | |
| GeneOntologyBiologicalProcess | presynaptic dense core vesicle exocytosis | 2.65e-05 | 10 | 127 | 3 | GO:0099525 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.63e-05 | 11 | 127 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | dense core granule docking | 3.76e-05 | 2 | 127 | 2 | GO:0061790 | |
| GeneOntologyBiologicalProcess | synaptic vesicle priming | 3.79e-05 | 31 | 127 | 4 | GO:0016082 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.05e-05 | 205 | 127 | 8 | GO:0061008 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 4.57e-05 | 153 | 127 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 4.82e-05 | 12 | 127 | 3 | GO:0052697 | |
| GeneOntologyBiologicalProcess | neuronal dense core vesicle exocytosis | 4.82e-05 | 12 | 127 | 3 | GO:0099011 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 5.51e-05 | 34 | 127 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 7.90e-05 | 14 | 127 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | dense core granule exocytosis | 9.83e-05 | 15 | 127 | 3 | GO:1990504 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor-beta signaling pathway | 9.83e-05 | 15 | 127 | 3 | GO:0035791 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | UNC13B CACNA1D SLC25A27 CACNA1S PDE3B ATP7A ACACB ADCY5 RYR1 RYR2 ITPR3 CKB RAB38 NOX1 SCN7A LRP1 PLCH1 | 1.09e-04 | 981 | 127 | 17 | GO:0019725 |
| GeneOntologyBiologicalProcess | protein localization to heterochromatin | 1.12e-04 | 3 | 127 | 2 | GO:0097355 | |
| GeneOntologyBiologicalProcess | protein-RNA complex assembly | 1.37e-04 | 244 | 127 | 8 | GO:0022618 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.48e-04 | 129 | 127 | 6 | GO:0048024 | |
| GeneOntologyBiologicalProcess | vesicle docking involved in exocytosis | 1.54e-04 | 44 | 127 | 4 | GO:0006904 | |
| GeneOntologyBiologicalProcess | protein-RNA complex organization | 1.80e-04 | 254 | 127 | 8 | GO:0071826 | |
| GeneOntologyBiologicalProcess | liver development | 2.58e-04 | 202 | 127 | 7 | GO:0001889 | |
| GeneOntologyBiologicalProcess | response to caffeine | 2.80e-04 | 21 | 127 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 2.95e-04 | 52 | 127 | 4 | GO:0042398 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.95e-04 | 52 | 127 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 3.00e-04 | 207 | 127 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | CELF6 CELF5 CELF4 ZNF622 HEATR1 USP16 CELF1 CELF2 CELF3 SNRPB2 SNRPE | 3.47e-04 | 515 | 127 | 11 | GO:0022613 |
| GeneOntologyBiologicalProcess | cyclic nucleotide biosynthetic process | 3.69e-04 | 23 | 127 | 3 | GO:0009190 | |
| GeneOntologyBiologicalProcess | cellular response to lead ion | 3.72e-04 | 5 | 127 | 2 | GO:0071284 | |
| GeneOntologyBiologicalProcess | action potential initiation | 3.72e-04 | 5 | 127 | 2 | GO:0099610 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 3.98e-04 | 217 | 127 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.43e-04 | 158 | 127 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic plasticity | 5.55e-04 | 6 | 127 | 2 | GO:0031914 | |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1D CACNA1S SCN11A ACACB RYR1 RYR2 CHUK JARID2 CKMT2 TOMM70 SCN7A | 5.74e-04 | 547 | 127 | 11 | GO:0003012 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 5.80e-04 | 62 | 127 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 6.06e-04 | 382 | 127 | 9 | GO:0016042 | |
| GeneOntologyBiologicalProcess | dense core granule localization | 6.67e-04 | 28 | 127 | 3 | GO:0032253 | |
| GeneOntologyBiologicalProcess | positive regulation of developmental growth | 6.89e-04 | 238 | 127 | 7 | GO:0048639 | |
| GeneOntologyBiologicalProcess | vesicle docking | 6.94e-04 | 65 | 127 | 4 | GO:0048278 | |
| GeneOntologyBiologicalProcess | establishment of mitotic sister chromatid cohesion | 7.74e-04 | 7 | 127 | 2 | GO:0034087 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 8.52e-04 | 321 | 127 | 8 | GO:0099003 | |
| GeneOntologyBiologicalProcess | vesicle localization | 8.57e-04 | 247 | 127 | 7 | GO:0051648 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite extension | 9.03e-04 | 31 | 127 | 3 | GO:1903861 | |
| GeneOntologyBiologicalProcess | phagosome maturation | 9.03e-04 | 31 | 127 | 3 | GO:0090382 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | UNC13B WASL ATP7A SEPTIN9 IQSEC2 USP16 CHMP2A CLDN1 NOX1 WASF2 TASOR | 9.54e-04 | 582 | 127 | 11 | GO:0044089 |
| GeneOntologyBiologicalProcess | response to metal ion | 1.09e-03 | 415 | 127 | 9 | GO:0010038 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 1.14e-03 | 127 | 127 | 5 | GO:0070252 | |
| GeneOntologyBiologicalProcess | secretory granule localization | 1.19e-03 | 34 | 127 | 3 | GO:0032252 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 1.20e-03 | 421 | 127 | 9 | GO:0048638 | |
| GeneOntologyBiologicalProcess | positive regulation of growth | 1.21e-03 | 339 | 127 | 8 | GO:0045927 | |
| GeneOntologyBiologicalProcess | regulation of dendrite extension | 1.29e-03 | 35 | 127 | 3 | GO:1903859 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 1.31e-03 | 77 | 127 | 4 | GO:0051289 | |
| GeneOntologyBiologicalProcess | secretion | UNC13B CACNA1D SCN11A PDE3B ATP7A ACACB ICA1 XDH PLA2G2E CHMP2A ADCY5 CHUK LRP1 KCNQ3 UNC13C RIMS2 UNC13A | 1.34e-03 | 1221 | 127 | 17 | GO:0046903 |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 2.45e-07 | 23 | 128 | 5 | GO:0098831 | |
| GeneOntologyCellularComponent | cell cortex | UNC13B WASL MYO9B SEPTIN9 IQSEC2 SEPTIN6 RYR1 MKLN1 SEPTIN11 UNC13C RIMS2 UNC13A | 3.06e-06 | 371 | 128 | 12 | GO:0005938 |
| GeneOntologyCellularComponent | cell cortex region | 7.99e-06 | 45 | 128 | 5 | GO:0099738 | |
| GeneOntologyCellularComponent | presynapse | UNC13B CACNA1D SCN11A ICA1 IQSEC2 RAB6B RGS7 SEPTIN6 ITPR3 VPS33B AP3B2 ITSN2 COPS4 UNC13C RIMS2 DNMBP UNC13A | 2.92e-05 | 886 | 128 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | ribbon synapse | 4.22e-05 | 32 | 128 | 4 | GO:0097470 | |
| GeneOntologyCellularComponent | cytoplasmic region | UNC13B RIBC2 SEPTIN9 IQSEC2 ARL8A AP3B2 UNC13C PACRG RIMS2 UNC13A | 7.60e-05 | 360 | 128 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | septin complex | 7.77e-05 | 14 | 128 | 3 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 7.77e-05 | 14 | 128 | 3 | GO:0005940 | |
| GeneOntologyCellularComponent | septin cytoskeleton | 1.18e-04 | 16 | 128 | 3 | GO:0032156 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.08e-04 | 88 | 128 | 5 | GO:0016529 | |
| GeneOntologyCellularComponent | postsynaptic specialization of symmetric synapse | 2.21e-04 | 4 | 128 | 2 | GO:0099629 | |
| GeneOntologyCellularComponent | presynaptic active zone | 2.34e-04 | 141 | 128 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | presynaptic membrane | 3.12e-04 | 277 | 128 | 8 | GO:0042734 | |
| GeneOntologyCellularComponent | cation channel complex | 6.20e-04 | 235 | 128 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | sarcoplasm | 6.86e-04 | 114 | 128 | 5 | GO:0016528 | |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B CACNA1D SCN11A IQSEC2 RGS7 ITSN2 MKLN1 LRP1 UNC13C RIMS2 UNC13A | 9.27e-04 | 583 | 128 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | UNC13B WASL NCALD ATP7A ICA1 WHAMM ARL8A CHMP2A SNX13 ITPR3 RAB38 RAB24 VPS33B AP3B2 MKLN1 LRP1 UNC13C UNC13A | 1.02e-03 | 1307 | 128 | 18 | GO:0030659 |
| GeneOntologyCellularComponent | calcium channel complex | 1.05e-03 | 73 | 128 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | organelle envelope | SLC25A24 SLC25A27 PARP11 ACACB RTEL1 CHMP2A QRICH2 RGS7 RYR2 ITPR3 CKMT2 PTPN1 TOMM70 MIGA2 PRELID2 SFXN2 PHLPP1 SLC25A44 CKMT1A | 1.17e-03 | 1435 | 128 | 19 | GO:0031967 |
| GeneOntologyCellularComponent | vesicle membrane | UNC13B WASL NCALD ATP7A ICA1 WHAMM ARL8A CHMP2A SNX13 ITPR3 RAB38 RAB24 VPS33B AP3B2 MKLN1 LRP1 UNC13C UNC13A | 1.19e-03 | 1325 | 128 | 18 | GO:0012506 |
| GeneOntologyCellularComponent | calyx of Held | 1.38e-03 | 36 | 128 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.62e-03 | 10 | 128 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 2.36e-03 | 12 | 128 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.52e-03 | 300 | 128 | 7 | GO:0008021 | |
| GeneOntologyCellularComponent | symmetric synapse | 2.78e-03 | 13 | 128 | 2 | GO:0032280 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 2.81e-03 | 46 | 128 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | early endosome | 2.86e-03 | 481 | 128 | 9 | GO:0005769 | |
| GeneOntologyCellularComponent | axon | UNC13B SCN11A ATP7A ARL8A ADCY9 SEPTIN6 ZPR1 AP3B2 LRP1 SEPTIN11 KCNQ3 UNC13C UNC13A | 3.24e-03 | 891 | 128 | 13 | GO:0030424 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1D SLC25A27 CACNA1S SCN11A ATP7A ICA1 DOCK10 RGS7 ADCY9 ITPR3 CKB ZPR1 LRP1 SEPTIN11 KCNQ3 CKMT1A | 3.42e-03 | 1228 | 128 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | I band | 3.59e-03 | 166 | 128 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | exocytic vesicle | 3.60e-03 | 320 | 128 | 7 | GO:0070382 | |
| Domain | Unc-13 | 2.72e-07 | 3 | 122 | 3 | IPR027080 | |
| Domain | Ion_trans_dom | 8.12e-07 | 114 | 122 | 8 | IPR005821 | |
| Domain | Ion_trans | 8.12e-07 | 114 | 122 | 8 | PF00520 | |
| Domain | ATP-gua_PtransN | 1.08e-06 | 4 | 122 | 3 | PF02807 | |
| Domain | PHOSPHAGEN_KINASE | 1.08e-06 | 4 | 122 | 3 | PS00112 | |
| Domain | ATP-gua_Ptrans | 1.08e-06 | 4 | 122 | 3 | PF00217 | |
| Domain | - | 1.08e-06 | 4 | 122 | 3 | 1.10.135.10 | |
| Domain | ATP-guanido_PTrfase_N | 1.08e-06 | 4 | 122 | 3 | IPR022413 | |
| Domain | ATP-guanido_PTrfase_AS | 1.08e-06 | 4 | 122 | 3 | IPR022415 | |
| Domain | ATP-guanido_PTrfase_cat | 1.08e-06 | 4 | 122 | 3 | IPR022414 | |
| Domain | PHOSPHAGEN_KINASE_N | 1.08e-06 | 4 | 122 | 3 | PS51509 | |
| Domain | PHOSPHAGEN_KINASE_C | 1.08e-06 | 4 | 122 | 3 | PS51510 | |
| Domain | Munc13_dom-2 | 2.69e-06 | 5 | 122 | 3 | IPR014772 | |
| Domain | ATP-guanido_PTrfase | 2.69e-06 | 5 | 122 | 3 | IPR000749 | |
| Domain | MHD2 | 2.69e-06 | 5 | 122 | 3 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 2.69e-06 | 5 | 122 | 3 | IPR019558 | |
| Domain | Membr_traf_MHD | 2.69e-06 | 5 | 122 | 3 | PF10540 | |
| Domain | DUF1041 | 2.69e-06 | 5 | 122 | 3 | SM01145 | |
| Domain | Gln_synth/guanido_kin_cat_dom | 5.36e-06 | 6 | 122 | 3 | IPR014746 | |
| Domain | RIH_assoc-dom | 5.36e-06 | 6 | 122 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.36e-06 | 6 | 122 | 3 | PF08709 | |
| Domain | RIH_assoc | 5.36e-06 | 6 | 122 | 3 | PF08454 | |
| Domain | RIH_dom | 5.36e-06 | 6 | 122 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.36e-06 | 6 | 122 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.36e-06 | 6 | 122 | 3 | IPR015925 | |
| Domain | - | 5.36e-06 | 6 | 122 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.36e-06 | 6 | 122 | 3 | PF01365 | |
| Domain | - | 5.36e-06 | 6 | 122 | 3 | 3.30.590.10 | |
| Domain | Munc13_1 | 9.34e-06 | 7 | 122 | 3 | IPR014770 | |
| Domain | MHD1 | 9.34e-06 | 7 | 122 | 3 | PS51258 | |
| Domain | DUF1041 | 9.34e-06 | 7 | 122 | 3 | PF06292 | |
| Domain | CAPS_dom | 9.34e-06 | 7 | 122 | 3 | IPR010439 | |
| Domain | UDPGT | 9.52e-06 | 21 | 122 | 4 | PF00201 | |
| Domain | UDPGT | 9.52e-06 | 21 | 122 | 4 | PS00375 | |
| Domain | UDP_glucos_trans | 9.52e-06 | 21 | 122 | 4 | IPR002213 | |
| Domain | EF-hand-dom_pair | SLC25A24 CACNA1S NCALD CABP5 RYR1 RYR2 ITSN2 SCN7A CALML4 PLCH1 | 1.90e-05 | 287 | 122 | 10 | IPR011992 |
| Domain | MIR | 3.16e-05 | 10 | 122 | 3 | PF02815 | |
| Domain | MIR_motif | 3.16e-05 | 10 | 122 | 3 | IPR016093 | |
| Domain | MIR | 3.16e-05 | 10 | 122 | 3 | PS50919 | |
| Domain | MIR | 3.16e-05 | 10 | 122 | 3 | SM00472 | |
| Domain | G_SEPTIN_dom | 7.41e-05 | 13 | 122 | 3 | IPR030379 | |
| Domain | Septin | 7.41e-05 | 13 | 122 | 3 | PF00735 | |
| Domain | G_SEPTIN | 7.41e-05 | 13 | 122 | 3 | PS51719 | |
| Domain | EFh | 8.06e-05 | 158 | 122 | 7 | SM00054 | |
| Domain | Septin | 9.39e-05 | 14 | 122 | 3 | IPR016491 | |
| Domain | Ryanodine_rcpt | 1.26e-04 | 3 | 122 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.26e-04 | 3 | 122 | 2 | IPR009460 | |
| Domain | RyR | 1.26e-04 | 3 | 122 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 1.26e-04 | 3 | 122 | 2 | PF06459 | |
| Domain | Ryan_recept | 1.26e-04 | 3 | 122 | 2 | IPR013333 | |
| Domain | EF_hand_dom | 1.43e-04 | 232 | 122 | 8 | IPR002048 | |
| Domain | A/G_cyclase_CS | 1.73e-04 | 17 | 122 | 3 | IPR018297 | |
| Domain | - | 2.07e-04 | 18 | 122 | 3 | 3.30.70.1230 | |
| Domain | Nucleotide_cyclase | 2.07e-04 | 18 | 122 | 3 | IPR029787 | |
| Domain | C2 | 2.21e-04 | 131 | 122 | 6 | PF00168 | |
| Domain | Guanylate_cyc | 2.44e-04 | 19 | 122 | 3 | PF00211 | |
| Domain | GUANYLATE_CYCLASE_2 | 2.44e-04 | 19 | 122 | 3 | PS50125 | |
| Domain | A/G_cyclase | 2.44e-04 | 19 | 122 | 3 | IPR001054 | |
| Domain | GUANYLATE_CYCLASE_1 | 2.44e-04 | 19 | 122 | 3 | PS00452 | |
| Domain | CYCc | 2.44e-04 | 19 | 122 | 3 | SM00044 | |
| Domain | VDCC_L_a1su | 2.52e-04 | 4 | 122 | 2 | IPR005446 | |
| Domain | C2 | 2.81e-04 | 137 | 122 | 6 | SM00239 | |
| Domain | - | 3.19e-04 | 261 | 122 | 8 | 1.10.238.10 | |
| Domain | WH2_dom | 3.32e-04 | 21 | 122 | 3 | IPR003124 | |
| Domain | C2 | 3.41e-04 | 142 | 122 | 6 | PS50004 | |
| Domain | - | 4.25e-04 | 148 | 122 | 6 | 2.60.40.150 | |
| Domain | RRM_1 | 4.36e-04 | 208 | 122 | 7 | PF00076 | |
| Domain | WH2 | 4.98e-04 | 24 | 122 | 3 | PS51082 | |
| Domain | C1_1 | 5.24e-04 | 57 | 122 | 4 | PF00130 | |
| Domain | Channel_four-helix_dom | 5.24e-04 | 57 | 122 | 4 | IPR027359 | |
| Domain | - | 5.24e-04 | 57 | 122 | 4 | 1.20.120.350 | |
| Domain | RRM | 5.62e-04 | 217 | 122 | 7 | SM00360 | |
| Domain | C2_dom | 7.31e-04 | 164 | 122 | 6 | IPR000008 | |
| Domain | RRM_dom | 7.33e-04 | 227 | 122 | 7 | IPR000504 | |
| Domain | RRM | 7.92e-04 | 230 | 122 | 7 | PS50102 | |
| Domain | EF_HAND_2 | 8.12e-04 | 231 | 122 | 7 | PS50222 | |
| Domain | ZF_DAG_PE_1 | 8.14e-04 | 64 | 122 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 8.14e-04 | 64 | 122 | 4 | PS50081 | |
| Domain | C1 | 8.63e-04 | 65 | 122 | 4 | SM00109 | |
| Domain | Ca_chan_IQ | 8.70e-04 | 7 | 122 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 8.70e-04 | 7 | 122 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 8.70e-04 | 7 | 122 | 2 | IPR014873 | |
| Domain | GPHH | 8.70e-04 | 7 | 122 | 2 | PF16905 | |
| Domain | GPHH_dom | 8.70e-04 | 7 | 122 | 2 | IPR031649 | |
| Domain | PE/DAG-bd | 9.14e-04 | 66 | 122 | 4 | IPR002219 | |
| Domain | - | 1.12e-03 | 244 | 122 | 7 | 3.30.70.330 | |
| Domain | EF-hand_8 | 1.40e-03 | 34 | 122 | 3 | PF13833 | |
| Domain | Nucleotide-bd_a/b_plait | 1.54e-03 | 258 | 122 | 7 | IPR012677 | |
| Domain | Na_channel_asu | 1.84e-03 | 10 | 122 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.84e-03 | 10 | 122 | 2 | IPR010526 | |
| Domain | Hud_Sxl_RNA | 1.84e-03 | 10 | 122 | 2 | IPR002343 | |
| Domain | Na_trans_assoc | 1.84e-03 | 10 | 122 | 2 | PF06512 | |
| Domain | VDCCAlpha1 | 1.84e-03 | 10 | 122 | 2 | IPR002077 | |
| Domain | EF-hand_7 | 2.33e-03 | 85 | 122 | 4 | PF13499 | |
| Domain | SPRY | 2.54e-03 | 87 | 122 | 4 | SM00449 | |
| Domain | SPRY | 3.36e-03 | 94 | 122 | 4 | PF00622 | |
| Domain | SPRY_dom | 3.36e-03 | 94 | 122 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 3.49e-03 | 95 | 122 | 4 | IPR001870 | |
| Domain | B302_SPRY | 3.49e-03 | 95 | 122 | 4 | PS50188 | |
| Domain | WH2 | 3.66e-03 | 14 | 122 | 2 | SM00246 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY | 1.04e-07 | 7 | 106 | 4 | M47940 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 9.57e-07 | 11 | 106 | 4 | M27681 | |
| Pathway | REACTOME_CREATINE_METABOLISM | 9.57e-07 | 11 | 106 | 4 | MM15402 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.47e-05 | 147 | 106 | 8 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.79e-05 | 151 | 106 | 8 | M39329 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.99e-05 | 22 | 106 | 4 | MM15888 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 2.35e-05 | 46 | 106 | 5 | M48105 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.51e-05 | 115 | 106 | 7 | M9387 | |
| Pathway | REACTOME_GLUCURONIDATION | 2.86e-05 | 24 | 106 | 4 | MM14599 | |
| Pathway | REACTOME_GLUCURONIDATION | 3.38e-05 | 25 | 106 | 4 | M17787 | |
| Pathway | WP_GLUCURONIDATION | 3.38e-05 | 25 | 106 | 4 | MM15820 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 3.38e-05 | 25 | 106 | 4 | M605 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 3.90e-05 | 51 | 106 | 5 | M17726 | |
| Pathway | WP_GLUCURONIDATION | 3.97e-05 | 26 | 106 | 4 | M39404 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 5.38e-05 | 28 | 106 | 4 | M19580 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 6.53e-05 | 11 | 106 | 3 | M47958 | |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 1.10e-04 | 145 | 106 | 7 | M45512 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.11e-04 | 101 | 106 | 6 | M1979 | |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 1.42e-04 | 14 | 106 | 3 | M39328 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.03e-04 | 39 | 106 | 4 | MM15695 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 2.47e-04 | 41 | 106 | 4 | M7399 | |
| Pathway | REACTOME_ASPIRIN_ADME | 3.55e-04 | 45 | 106 | 4 | MM15694 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.67e-04 | 19 | 106 | 3 | M47760 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | WASL MYO9B DOCK10 WHAMM PREX2 CKB NOX1 WASF2 ITSN2 COPS4 DNMBP | 5.64e-04 | 450 | 106 | 11 | M27078 |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 5.79e-04 | 90 | 106 | 5 | M835 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 6.20e-04 | 52 | 106 | 4 | M14171 | |
| Pathway | KEGG_ARGININE_AND_PROLINE_METABOLISM | 7.15e-04 | 54 | 106 | 4 | M2551 | |
| Pathway | WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION | 7.67e-04 | 55 | 106 | 4 | M39763 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 7.67e-04 | 55 | 106 | 4 | M14933 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 7.83e-04 | 261 | 106 | 8 | M42565 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 8.24e-04 | 6 | 106 | 2 | M47762 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.07e-03 | 154 | 106 | 6 | MM15974 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.15e-03 | 156 | 106 | 6 | M39475 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.32e-03 | 219 | 106 | 7 | M29836 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.32e-03 | 108 | 106 | 5 | M17034 | |
| Pathway | KEGG_RETINOL_METABOLISM | 1.36e-03 | 64 | 106 | 4 | M9488 | |
| Pathway | REACTOME_DRUG_ADME | 1.37e-03 | 109 | 106 | 5 | M45012 | |
| Pathway | PID_CDC42_REG_PATHWAY | 1.45e-03 | 30 | 106 | 3 | M83 | |
| Pubmed | A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. | 2.43e-15 | 6 | 130 | 6 | 10893231 | |
| Pubmed | 4.04e-12 | 6 | 130 | 5 | 11158314 | ||
| Pubmed | An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury. | 9.29e-10 | 5 | 130 | 4 | 34706221 | |
| Pubmed | Isolation and characterization of the gene and cDNA encoding human mitochondrial creatine kinase. | 9.29e-10 | 5 | 130 | 4 | 2914937 | |
| Pubmed | 2.78e-09 | 6 | 130 | 4 | 32527940 | ||
| Pubmed | 2.78e-09 | 6 | 130 | 4 | 20297805 | ||
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 6.47e-09 | 7 | 130 | 4 | 8467709 | |
| Pubmed | 6.47e-09 | 7 | 130 | 4 | 10893433 | ||
| Pubmed | 6.47e-09 | 7 | 130 | 4 | 27512039 | ||
| Pubmed | 6.47e-09 | 7 | 130 | 4 | 8464825 | ||
| Pubmed | 6.47e-09 | 7 | 130 | 4 | 27514509 | ||
| Pubmed | Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones. | 6.47e-09 | 7 | 130 | 4 | 36398873 | |
| Pubmed | 1.29e-08 | 8 | 130 | 4 | 17179145 | ||
| Pubmed | 1.29e-08 | 8 | 130 | 4 | 20610558 | ||
| Pubmed | 1.29e-08 | 8 | 130 | 4 | 18052087 | ||
| Pubmed | 2.31e-08 | 9 | 130 | 4 | 22511988 | ||
| Pubmed | 3.85e-08 | 10 | 130 | 4 | 23642732 | ||
| Pubmed | 3.85e-08 | 10 | 130 | 4 | 11465080 | ||
| Pubmed | 3.85e-08 | 10 | 130 | 4 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 3.85e-08 | 10 | 130 | 4 | 22558097 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 23658173 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 29519853 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 17639022 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 33105896 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 28806770 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22966208 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 12847094 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 15988013 | ||
| Pubmed | Molecular and functional architecture of striatal dopamine release sites. | 6.03e-08 | 11 | 130 | 4 | 34767769 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 9.01e-08 | 12 | 130 | 4 | 20308471 | |
| Pubmed | 9.01e-08 | 12 | 130 | 4 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 9.01e-08 | 12 | 130 | 4 | 11434514 | |
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 1.30e-07 | 13 | 130 | 4 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 1.30e-07 | 13 | 130 | 4 | 25246029 | |
| Pubmed | 1.81e-07 | 14 | 130 | 4 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.81e-07 | 14 | 130 | 4 | 10836148 | |
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.81e-07 | 14 | 130 | 4 | 14672974 | |
| Pubmed | 1.81e-07 | 14 | 130 | 4 | 9295054 | ||
| Pubmed | 1.96e-07 | 226 | 130 | 9 | 31452512 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 17558305 | ||
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 3.28e-07 | 16 | 130 | 4 | 19414484 | |
| Pubmed | WASL SEPTIN9 IQSEC2 PSMD2 CCT4 SEPTIN6 CKB TOMM70 GUCY1A2 AP3B2 ITSN2 SEPTIN11 KCNQ3 PLCH1 UNC13A TP53BP2 LRRFIP1 CKMT1A DNPEP HDLBP | 3.79e-07 | 1431 | 130 | 20 | 37142655 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 4.27e-07 | 17 | 130 | 4 | 20639394 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 19145258 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 32755572 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 22248876 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 5.08e-07 | 5 | 130 | 3 | 33139401 | |
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 20565459 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 15057901 | ||
| Pubmed | Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis. | 5.08e-07 | 5 | 130 | 3 | 26575293 | |
| Pubmed | 5.48e-07 | 18 | 130 | 4 | 20056724 | ||
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 6.92e-07 | 19 | 130 | 4 | 23281178 | |
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 23463619 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.01e-06 | 6 | 130 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.01e-06 | 6 | 130 | 3 | 16844763 | |
| Pubmed | MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. | 1.01e-06 | 6 | 130 | 3 | 19720736 | |
| Pubmed | NCALD ACACB SEPTIN9 IQSEC2 PSMD2 CCT4 ARL8A RAB6B SEPTIN6 RYR2 PTPN1 MKLN1 SEPTIN11 KCNQ3 UNC13A LRRFIP1 HDLBP | 1.28e-06 | 1139 | 130 | 17 | 36417873 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 11860456 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.87e-06 | 24 | 130 | 4 | 24625756 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACACB NEBL SEPTIN9 ZNF622 CCT4 HEATR1 USP16 CKB WASF2 YLPM1 COPS4 TASOR NIPBL TP53BP2 HDLBP | 2.34e-06 | 934 | 130 | 15 | 33916271 |
| Pubmed | Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release. | 2.61e-06 | 26 | 130 | 4 | 17124501 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.82e-06 | 8 | 130 | 3 | 19033399 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 2.82e-06 | 8 | 130 | 3 | 25609709 | |
| Pubmed | SLC25A24 NEBL ZNF622 WHAMM CCT4 HEATR1 ZFC3H1 RAB6B JARID2 TOMM70 WASF2 ITSN2 SEPTIN11 DNMBP TASOR SNRPE NIPBL CKMT1A HDLBP | 3.15e-06 | 1497 | 130 | 19 | 31527615 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SEPTIN9 CCT4 CHMP2A SEPTIN6 CKB CKM SMC3 AP3B2 SEPTIN11 SNRPB2 SNRPE NIPBL LRRFIP1 CKMT1A | 3.73e-06 | 847 | 130 | 14 | 35235311 |
| Pubmed | Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. | 4.22e-06 | 9 | 130 | 3 | 20732626 | |
| Pubmed | Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission. | 4.22e-06 | 9 | 130 | 3 | 18809578 | |
| Pubmed | 5.03e-06 | 66 | 130 | 5 | 19898482 | ||
| Pubmed | 5.42e-06 | 31 | 130 | 4 | 15217342 | ||
| Pubmed | 5.88e-06 | 182 | 130 | 7 | 15102471 | ||
| Pubmed | 6.01e-06 | 10 | 130 | 3 | 18434328 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SLC25A24 PSMD2 CCT4 ARL8A HEATR1 CDC45 CKB JARID2 PTPN1 TOMM70 VPS33B SMC3 COPS4 SNRPB2 NIPBL CKMT1A DNPEP HDLBP | 6.28e-06 | 1425 | 130 | 18 | 30948266 |
| Pubmed | SCN11A NCALD ACACB PSMD2 CCT4 ARL8A HEATR1 ZFC3H1 RYR2 PPP4R4 CHUK GUCY1A2 ITSN2 YLPM1 PLCH1 RIMS2 TASOR NIPBL | 7.38e-06 | 1442 | 130 | 18 | 35575683 | |
| Pubmed | 8.24e-06 | 11 | 130 | 3 | 18695635 | ||
| Pubmed | SEPTIN9 PSMD2 CCT4 CKB SMC3 YLPM1 MKLN1 SEPTIN11 SNRPB2 SNRPE LRRFIP1 CKMT1A HDLBP | 1.14e-05 | 809 | 130 | 13 | 32129710 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.25e-05 | 38 | 130 | 4 | 30786075 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21677511 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19337554 | ||
| Pubmed | Maurocalcin and its analog MCaE12A facilitate Ca2+ mobilization in cardiomyocytes. | 1.39e-05 | 2 | 130 | 2 | 33034621 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12954602 | ||
| Pubmed | Dissimilarity in the folding of human cytosolic creatine kinase isoenzymes. | 1.39e-05 | 2 | 130 | 2 | 21931810 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23468433 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 26643602 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23071115 | ||
| Pubmed | Investigating the genetic susceptibility to exertional heat illness. | 1.39e-05 | 2 | 130 | 2 | 32054689 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12070347 | ||
| Pubmed | Myocardial creatine kinase expression after left ventricular assist device support. | 1.39e-05 | 2 | 130 | 2 | 12039490 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12871971 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 25547628 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17561838 | ||
| Pubmed | Creatine kinase transcript accumulation: effect of nerve during muscle development. | 1.39e-05 | 2 | 130 | 2 | 10417818 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23070049 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9748661 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21575570 | ||
| Pubmed | Modulation of Cav1.3 Ca2+ channel gating by Rab3 interacting molecule. | 1.39e-05 | 2 | 130 | 2 | 20363327 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 11389199 | ||
| Pubmed | Exploring the role of the active site cysteine in human muscle creatine kinase. | 1.39e-05 | 2 | 130 | 2 | 16981706 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12496092 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 15105171 | ||
| Cytoband | 2q37 | 1.82e-06 | 31 | 130 | 4 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 4.78e-05 | 226 | 130 | 6 | chr2q37 | |
| Cytoband | 1q43 | 4.18e-04 | 51 | 130 | 3 | 1q43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q43 | 7.43e-04 | 62 | 130 | 3 | chr1q43 | |
| GeneFamily | UNC13 homologs | 5.78e-07 | 4 | 96 | 3 | 836 | |
| GeneFamily | UDP glucuronosyltransferases | 2.39e-05 | 32 | 96 | 4 | 363 | |
| GeneFamily | Septins | 3.99e-05 | 13 | 96 | 3 | 732 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 7.73e-05 | 16 | 96 | 3 | 14 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 8.34e-05 | 3 | 96 | 2 | 287 | |
| GeneFamily | RNA binding motif containing | 1.40e-04 | 213 | 96 | 7 | 725 | |
| GeneFamily | EF-hand domain containing | 1.66e-04 | 219 | 96 | 7 | 863 | |
| GeneFamily | Classical BAR domain containing | 7.65e-04 | 8 | 96 | 2 | 1292 | |
| GeneFamily | Adenylate cyclases|Deafness associated genes | 1.22e-03 | 10 | 96 | 2 | 53 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.79e-03 | 181 | 96 | 5 | 694 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.80e-03 | 15 | 96 | 2 | 26 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 4.99e-03 | 65 | 96 | 3 | 388 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.21e-03 | 66 | 96 | 3 | 722 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.35e-03 | 26 | 96 | 2 | 253 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SLC25A24 MYO9B SEPTIN9 RGS7 ADCY9 SNX13 JARID2 PTPN1 SMC3 ITSN2 MKLN1 PHLPP1 DNMBP TASOR NIPBL TP53BP2 LRRFIP1 | 1.08e-06 | 856 | 129 | 17 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL | CELF5 CELF4 ATP7A ICA1 RAB6B RGS7 RYR2 PACRG RIMS2 SRRM3 CKMT1A | 2.62e-06 | 375 | 129 | 11 | M45799 |
| Coexpression | GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN | 6.92e-06 | 200 | 129 | 8 | M4358 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | CELF6 CELF5 CELF4 ICA1 SEPTIN6 RAB24 CELF3 AP3B2 SCN7A KCNQ3 RIMS2 | 1.46e-05 | 450 | 129 | 11 | M39072 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL | 3.20e-05 | 122 | 129 | 6 | M45802 | |
| Coexpression | LU_AGING_BRAIN_UP | 4.95e-05 | 263 | 129 | 8 | M5547 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 5.99e-05 | 199 | 129 | 7 | M5251 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN | 6.18e-05 | 200 | 129 | 7 | M7744 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | CACNA1D CELF5 CELF4 ICA1 RGS7 RYR2 CELF2 KCNQ3 HERC1 RIMS2 SRRM3 | 1.71e-11 | 200 | 129 | 11 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-10 | 198 | 129 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-10 | 198 | 129 | 10 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-09 | 198 | 129 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.71e-09 | 198 | 129 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.93e-08 | 188 | 129 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-07 | 196 | 129 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-07 | 198 | 129 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma-2|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.35e-07 | 146 | 129 | 7 | bc2adef529d0bbfcccef7435401a47a6ffcc1832 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Neuroendocrine_Carcinoma|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.35e-07 | 146 | 129 | 7 | 72c1e7e0c2b6ff6c4084af61fa19c2b8eab16eda | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.57e-07 | 161 | 129 | 7 | 76c993a4533362db2250c88b3ee3ede55362d54e | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.59e-07 | 170 | 129 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.71e-07 | 174 | 129 | 7 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-06 | 187 | 129 | 7 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.39e-06 | 190 | 129 | 7 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.44e-06 | 191 | 129 | 7 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.44e-06 | 191 | 129 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.44e-06 | 191 | 129 | 7 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.44e-06 | 191 | 129 | 7 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.54e-06 | 193 | 129 | 7 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.59e-06 | 194 | 129 | 7 | f64da5f62e29253d60b9546edf734ba5c17daae1 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-06 | 194 | 129 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.59e-06 | 194 | 129 | 7 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-06 | 196 | 129 | 7 | 36b4f08fc038dfde6343ff0869e1a027d882adb5 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 197 | 129 | 7 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-06 | 197 | 129 | 7 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-06 | 199 | 129 | 7 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-06 | 199 | 129 | 7 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.95e-06 | 200 | 129 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 5.04e-06 | 150 | 129 | 6 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.32e-06 | 167 | 129 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-06 | 167 | 129 | 6 | f33cef917fa733adf6d5a9a9e989a4d9fd462a8f | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-06 | 169 | 129 | 6 | 46f0f0de9a0894c454f93032e7a7a800f47c8276 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.98e-06 | 169 | 129 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 170 | 129 | 6 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 171 | 129 | 6 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | COVID-19_Mild-Neu_2|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.10e-05 | 172 | 129 | 6 | f5fd08b42c002d4693646b27e7b708eceb49524f | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 173 | 129 | 6 | 9a3500b06d00d1d4ee42910a3a73327b21beab52 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 1.14e-05 | 173 | 129 | 6 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-05 | 174 | 129 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-05 | 174 | 129 | 6 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 176 | 129 | 6 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 176 | 129 | 6 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.26e-05 | 176 | 129 | 6 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-05 | 177 | 129 | 6 | 3cb96d7d56c9ff90f1f8a6caaf49e580e2524c7d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 178 | 129 | 6 | 76e71fff99cf64302e2e3c0d66dd8ba0ff13624e | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 178 | 129 | 6 | 82f78ea1ea3ff3e2347cd8bc2f06e2a10e96f220 | |
| ToppCell | droplet-Lung-30m-Epithelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 178 | 129 | 6 | 5442bc52b8e902da1383f44d97a9f95e471a8d4d | |
| ToppCell | droplet-Lung-30m-Epithelial-alveolar_epithelial-type_II_pneumocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 178 | 129 | 6 | 523b286ebe0359c7f1902f28cbd71f452626fc0d | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.38e-05 | 179 | 129 | 6 | b7a2429d07d7146b32b3552a5f2a2542105a71e0 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.38e-05 | 179 | 129 | 6 | 06f92c884189197c86793191c05f65e34925c097 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.43e-05 | 180 | 129 | 6 | 57689ccbbd44c0e78e061edd87d3102c5f2dcc9a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-05 | 181 | 129 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 1.47e-05 | 181 | 129 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.52e-05 | 182 | 129 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 183 | 129 | 6 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-05 | 183 | 129 | 6 | 7e2bac8b005155888ff4b41ef2e1d975dc17abc7 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-05 | 183 | 129 | 6 | b0b835f3b1de1bd46a47e1b805aa8994cd3a4e3e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-05 | 184 | 129 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.67e-05 | 185 | 129 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 185 | 129 | 6 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.72e-05 | 186 | 129 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 187 | 129 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.77e-05 | 187 | 129 | 6 | 98477ba04a42a8da80a72f41a182429f46283595 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.77e-05 | 187 | 129 | 6 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 188 | 129 | 6 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.83e-05 | 188 | 129 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.83e-05 | 188 | 129 | 6 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 188 | 129 | 6 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.83e-05 | 188 | 129 | 6 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | wk_15-18-Epithelial-PNS-PCP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.88e-05 | 189 | 129 | 6 | 22c927d2691b867fbdee1fbee042a6d3f7eadd7d | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.88e-05 | 189 | 129 | 6 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.88e-05 | 189 | 129 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.88e-05 | 189 | 129 | 6 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 189 | 129 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.88e-05 | 189 | 129 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-05 | 189 | 129 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 190 | 129 | 6 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 190 | 129 | 6 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 190 | 129 | 6 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.94e-05 | 190 | 129 | 6 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-05 | 190 | 129 | 6 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.94e-05 | 190 | 129 | 6 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.94e-05 | 190 | 129 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | 11.5-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 2.00e-05 | 191 | 129 | 6 | c1bb3ae5c297f55cdadf5b6e53d5296389d5099e | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.06e-05 | 192 | 129 | 6 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.12e-05 | 193 | 129 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.12e-05 | 193 | 129 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.12e-05 | 193 | 129 | 6 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.12e-05 | 193 | 129 | 6 | 8603d1a38955ad2529d04e4704467c73ea5bfbda | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.18e-05 | 194 | 129 | 6 | b30379f8dc41c86c746af9930541fbb4819d8fa0 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 195 | 129 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-05 | 195 | 129 | 6 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 195 | 129 | 6 | 5f33ece997f074598b4201ff74f592ee07c86a06 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.31e-05 | 196 | 129 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-05 | 196 | 129 | 6 | 95544097577f20ed7f4144bd940471cde0617554 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.31e-05 | 196 | 129 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | IPF-Lymphoid-T|Lymphoid / Disease state, Lineage and Cell class | 2.31e-05 | 196 | 129 | 6 | 6e70c48a63d9673eb16b0847c1bd88eecc2f7a3c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-05 | 196 | 129 | 6 | 72b6a68ee760599ea86cd2d712bfd17b7b4ee417 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 196 | 129 | 6 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| Drug | M-HN | 6.42e-12 | 31 | 130 | 8 | CID000015450 | |
| Drug | lamotrigine | CACNA1D CACNA1S UGT1A10 UGT1A8 UGT1A7 UGT1A9 RYR1 RYR2 ITPR3 SCN7A | 1.27e-09 | 116 | 130 | 10 | CID000003878 |
| Drug | bepridil | 2.86e-09 | 126 | 130 | 10 | CID000002351 | |
| Drug | naringenin chalcone | 5.05e-09 | 5 | 130 | 4 | ctd:C027329 | |
| Drug | ATP gamma-(N-(2-chloroethyl)-N-methyl)amide | 5.05e-09 | 5 | 130 | 4 | CID000174813 | |
| Drug | epoxycreatine | 5.05e-09 | 5 | 130 | 4 | CID000194341 | |
| Drug | gamma-benzylamide ATP | 5.05e-09 | 5 | 130 | 4 | CID000194049 | |
| Drug | vitamin K1 diacetate | 5.05e-09 | 5 | 130 | 4 | CID006441272 | |
| Drug | ATP gamma-p-azidoanilide | 5.05e-09 | 5 | 130 | 4 | CID003035480 | |
| Drug | anthrarobin | 5.05e-09 | 5 | 130 | 4 | ctd:C032186 | |
| Drug | homocyclocreatine | 5.05e-09 | 5 | 130 | 4 | CID000128636 | |
| Drug | N-2-hydroxyethyl-N-methyl-gamma-amide ATP | 5.05e-09 | 5 | 130 | 4 | CID000195952 | |
| Drug | steroid U | 5.05e-09 | 5 | 130 | 4 | CID000133659 | |
| Drug | gamma-anilide ATP | 5.05e-09 | 5 | 130 | 4 | CID000193883 | |
| Drug | papaverine | CACNA1D CACNA1S PDE3B XDH ADCY5 ADCY9 RYR1 RYR2 ITPR3 GUCY1A2 PLCH1 | 5.64e-09 | 176 | 130 | 11 | CID000004680 |
| Drug | 2-hydroxyestrone | 6.97e-09 | 13 | 130 | 5 | ctd:C024980 | |
| Drug | NSC759576 | CACNA1D CACNA1S ADCY5 ADCY9 RYR1 RYR2 ITPR3 CKB CKM CKMT2 CKMT1A | 1.32e-08 | 191 | 130 | 11 | CID000003075 |
| Drug | phosphocyclocreatine | 1.51e-08 | 6 | 130 | 4 | CID000124896 | |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 1.51e-08 | 6 | 130 | 4 | ctd:C543211 | |
| Drug | Creatine | 1.51e-08 | 6 | 130 | 4 | DB00148 | |
| Drug | CoADP | 1.51e-08 | 6 | 130 | 4 | CID000194171 | |
| Drug | alloin | 1.51e-08 | 6 | 130 | 4 | ctd:C006457 | |
| Drug | PTMSA | 1.51e-08 | 6 | 130 | 4 | CID000006934 | |
| Drug | hexahydro-4-methyl phthalic anhydride | 1.51e-08 | 6 | 130 | 4 | CID000086876 | |
| Drug | 2',5'-dihydroxychalcone | 1.51e-08 | 6 | 130 | 4 | ctd:C107497 | |
| Drug | phenylbutazone | 2.50e-08 | 83 | 130 | 8 | CID000004781 | |
| Drug | gemcadiol | 3.50e-08 | 7 | 130 | 4 | CID000037147 | |
| Drug | AC1L1YAP | 3.50e-08 | 7 | 130 | 4 | CID000063066 | |
| Drug | 2-nitrobenzenesulphonyl fluoride | 3.50e-08 | 7 | 130 | 4 | CID000097375 | |
| Drug | 1-carboxymethyl-2-iminohexahydropyrimidine | 3.50e-08 | 7 | 130 | 4 | CID000193725 | |
| Drug | 2',4'-dihydroxychalcone | 3.50e-08 | 7 | 130 | 4 | ctd:C059354 | |
| Drug | ApApG | 4.53e-08 | 18 | 130 | 5 | CID003081975 | |
| Drug | anisole | 5.22e-08 | 36 | 130 | 6 | CID000007519 | |
| Drug | 1,4-dihydroxyanthraquinone | 6.98e-08 | 8 | 130 | 4 | ctd:C034890 | |
| Drug | Rh(H2O)4PP | 6.98e-08 | 8 | 130 | 4 | CID000194736 | |
| Drug | succinylcholine | 7.97e-08 | 64 | 130 | 7 | CID000005314 | |
| Drug | AC1L1TJF | 9.90e-08 | 66 | 130 | 7 | CID000003377 | |
| Drug | AC1MRQNQ | 1.25e-07 | 9 | 130 | 4 | CID003522271 | |
| Drug | DHPASiU | 1.25e-07 | 9 | 130 | 4 | CID000197602 | |
| Drug | lombricine | 1.25e-07 | 9 | 130 | 4 | CID000159847 | |
| Drug | 3-iodophenol | 1.25e-07 | 9 | 130 | 4 | CID000012272 | |
| Drug | BIIB513 | 1.25e-07 | 9 | 130 | 4 | CID006918374 | |
| Drug | AC1L4J7U | 1.25e-07 | 9 | 130 | 4 | CID000186631 | |
| Drug | Chebi:32663 | 1.25e-07 | 9 | 130 | 4 | CID005460873 | |
| Drug | caffeine | CACNA1D CACNA1S PDE3B XDH CHMP2A ADCY5 ADCY9 RYR1 RYR2 CDC45 ITPR3 CKB CKM CKMT2 PLCH1 CKMT1A | 1.39e-07 | 562 | 130 | 16 | CID000002519 |
| Drug | Dantrolene-13C3 | 1.54e-07 | 145 | 130 | 9 | CID000002951 | |
| Drug | ezetimibe | 1.73e-07 | 147 | 130 | 9 | CID000150311 | |
| Drug | phenanthridine | 1.74e-07 | 23 | 130 | 5 | CID000009189 | |
| Drug | pyridinophane cryptand | 2.08e-07 | 10 | 130 | 4 | CID006454246 | |
| Drug | ONO-3144 | 2.08e-07 | 10 | 130 | 4 | CID000166446 | |
| Drug | 2,6-dihydroxyanthraquinone | 2.08e-07 | 10 | 130 | 4 | ctd:C034889 | |
| Drug | retigabine | 3.11e-07 | 48 | 130 | 6 | CID000121892 | |
| Drug | AC1L4VLE | 3.25e-07 | 11 | 130 | 4 | CID000193097 | |
| Drug | stannous pyrophosphate | 3.25e-07 | 11 | 130 | 4 | CID000066379 | |
| Drug | 4-nitrophenyl)imidazole | 3.25e-07 | 11 | 130 | 4 | CID000123155 | |
| Drug | AC1O5XMV | 3.25e-07 | 11 | 130 | 4 | CID006442661 | |
| Drug | Thymol | 3.36e-07 | 26 | 130 | 5 | ctd:D013943 | |
| Drug | licochalcone A | 4.10e-07 | 27 | 130 | 5 | ctd:C070840 | |
| Drug | 1-hydroxypyrene | 4.50e-07 | 51 | 130 | 6 | ctd:C033146 | |
| Drug | N-OH-DABZ | 4.85e-07 | 12 | 130 | 4 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 4.85e-07 | 12 | 130 | 4 | CID000088735 | |
| Drug | 4-hydroxyestrone | 4.85e-07 | 12 | 130 | 4 | ctd:C026418 | |
| Drug | 2,4,6-TCB | 4.85e-07 | 12 | 130 | 4 | CID000037247 | |
| Drug | nicotinoylprocaine | 4.85e-07 | 12 | 130 | 4 | CID000159667 | |
| Drug | danshenxinkun A | 4.85e-07 | 12 | 130 | 4 | CID000149138 | |
| Drug | nonanoyl-N-methylglucamide | 4.85e-07 | 12 | 130 | 4 | CID000160090 | |
| Drug | Dhga | 4.85e-07 | 12 | 130 | 4 | CID000467478 | |
| Drug | 7,7,7-triphenylheptanoic acid | 4.85e-07 | 12 | 130 | 4 | CID000276709 | |
| Drug | AC1NSVWC | 4.85e-07 | 12 | 130 | 4 | CID005317648 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 5.98e-07 | 29 | 130 | 5 | CID005375667 | |
| Drug | gemfibrozil | UGT1A10 UGT1A8 UGT1A7 UGT1A9 CKB CKM CKMT2 ZPR1 SNRPE CKMT1A | 6.10e-07 | 222 | 130 | 10 | CID000003463 |
| Drug | tritanol | 6.97e-07 | 13 | 130 | 4 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 6.97e-07 | 13 | 130 | 4 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 6.97e-07 | 13 | 130 | 4 | CID000000411 | |
| Drug | alizarin | 6.97e-07 | 13 | 130 | 4 | ctd:C010078 | |
| Drug | hydratropic acid | 7.25e-07 | 4 | 130 | 3 | ctd:C013025 | |
| Drug | 2-vanillin | 7.25e-07 | 4 | 130 | 3 | ctd:C060843 | |
| Drug | diphenylacetic acid | 7.25e-07 | 4 | 130 | 3 | ctd:C037760 | |
| Drug | 4-ethylphenol | 8.47e-07 | 31 | 130 | 5 | CID000031242 | |
| Drug | 2-chloromercuri-4-nitrophenol | 9.72e-07 | 14 | 130 | 4 | CID000090545 | |
| Drug | propranolol glucuronide | 9.72e-07 | 14 | 130 | 4 | CID000119515 | |
| Drug | PCB-61 | 9.72e-07 | 14 | 130 | 4 | CID000036401 | |
| Drug | lanthanum | 1.16e-06 | 136 | 130 | 8 | CID000023926 | |
| Drug | CNS 1145 | 1.17e-06 | 33 | 130 | 5 | CID000190902 | |
| Drug | IHC-64 | 1.17e-06 | 33 | 130 | 5 | CID000162753 | |
| Drug | geniposide | 1.17e-06 | 33 | 130 | 5 | CID000107848 | |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 1.32e-06 | 15 | 130 | 4 | CID000040469 | |
| Drug | FPL 64176 | 1.32e-06 | 15 | 130 | 4 | CID000003423 | |
| Drug | g-eq | 1.32e-06 | 15 | 130 | 4 | CID000447767 | |
| Drug | afloqualone | 1.32e-06 | 15 | 130 | 4 | CID000002040 | |
| Drug | naphthyl sulphate | 1.32e-06 | 15 | 130 | 4 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 1.32e-06 | 15 | 130 | 4 | CID000010752 | |
| Drug | bergamottin | 1.32e-06 | 15 | 130 | 4 | ctd:C068337 | |
| Drug | taurocyamine | 1.32e-06 | 15 | 130 | 4 | CID000068340 | |
| Drug | sulforaphane nitrile | 1.32e-06 | 15 | 130 | 4 | CID000543743 | |
| Drug | quercetin-3,4'-diglucoside | 1.75e-06 | 16 | 130 | 4 | CID005320835 | |
| Drug | calcium dobesilate | 1.75e-06 | 16 | 130 | 4 | CID000017507 | |
| Drug | 1'-hydroxyestragole | 1.75e-06 | 16 | 130 | 4 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.75e-06 | 16 | 130 | 4 | CID005497144 | |
| Drug | isovaleric acid | 1.80e-06 | 5 | 130 | 3 | ctd:C008216 | |
| Disease | vitamin D deficiency | 2.02e-10 | 37 | 126 | 7 | EFO_0003762 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.58e-09 | 5 | 126 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.58e-09 | 5 | 126 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.58e-09 | 5 | 126 | 4 | EFO_0801853 | |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 4.72e-09 | 6 | 126 | 4 | EFO_0800566 | |
| Disease | X-21441 measurement | 7.78e-09 | 17 | 126 | 5 | EFO_0800814 | |
| Disease | X-21339 measurement | 1.10e-08 | 7 | 126 | 4 | EFO_0800808 | |
| Disease | X-11793--oxidized bilirubin measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0021260 | |
| Disease | Succinimide measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0022118 | |
| Disease | X-11530 measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0800696 | |
| Disease | X-10458 measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0800692 | |
| Disease | X-24849 measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0800909 | |
| Disease | serum N-desmethylclozapine measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0600038 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0802740 | |
| Disease | X-16946 measurement | 2.19e-08 | 8 | 126 | 4 | EFO_0800766 | |
| Disease | X-11442 measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0021236 | |
| Disease | X-11441 measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0801036 | |
| Disease | X-11880 measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 3.93e-08 | 9 | 126 | 4 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 3.93e-08 | 9 | 126 | 4 | EFO_0004570, GO_0009410 | |
| Disease | vitamin D measurement, COVID-19 | 6.47e-08 | 49 | 126 | 6 | EFO_0004631, MONDO_0100096 | |
| Disease | bilirubin measurement, response to tenofovir | 6.53e-08 | 10 | 126 | 4 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 6.53e-08 | 10 | 126 | 4 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 6.53e-08 | 10 | 126 | 4 | EFO_0802185 | |
| Disease | X-23974 measurement | 6.53e-08 | 10 | 126 | 4 | EFO_0800867 | |
| Disease | indole-3-carboxylate measurement | 7.60e-08 | 3 | 126 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 7.60e-08 | 3 | 126 | 3 | EFO_0022216 | |
| Disease | pregnenetriol sulfate measurement | 1.02e-07 | 11 | 126 | 4 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 1.02e-07 | 11 | 126 | 4 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 1.02e-07 | 11 | 126 | 4 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.02e-07 | 11 | 126 | 4 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.02e-07 | 11 | 126 | 4 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.02e-07 | 11 | 126 | 4 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 1.53e-07 | 12 | 126 | 4 | EFO_0800079 | |
| Disease | biliverdin measurement | 1.53e-07 | 12 | 126 | 4 | EFO_0021033 | |
| Disease | pregnenetriol disulfate measurement | 2.20e-07 | 13 | 126 | 4 | EFO_0800587 | |
| Disease | X-24588 measurement | 2.20e-07 | 13 | 126 | 4 | EFO_0800898 | |
| Disease | retinol dehydrogenase 16 measurement | 2.20e-07 | 13 | 126 | 4 | EFO_0802007 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 7.23e-07 | 17 | 126 | 4 | EFO_0004611, EFO_0007800 | |
| Disease | angiopoietin-related protein 1 measurement | 9.26e-07 | 18 | 126 | 4 | EFO_0801382 | |
| Disease | tissue factor measurement | 1.79e-06 | 21 | 126 | 4 | EFO_0010623 | |
| Disease | urate measurement, spine bone mineral density | 5.01e-06 | 58 | 126 | 5 | EFO_0004531, EFO_0007701 | |
| Disease | neuroblastoma, cutaneous melanoma | 5.99e-06 | 28 | 126 | 4 | EFO_0000389, EFO_0000621 | |
| Disease | xanthurenate measurement | 6.93e-06 | 29 | 126 | 4 | EFO_0010551 | |
| Disease | response to dolutegravir | 7.97e-06 | 30 | 126 | 4 | EFO_0600017 | |
| Disease | indoleacetate measurement | 8.93e-06 | 10 | 126 | 3 | EFO_0021015 | |
| Disease | Malignant hyperthermia, susceptibility to | 1.81e-05 | 2 | 126 | 2 | cv:C5437603 | |
| Disease | Malignant hyperthermia | 1.81e-05 | 2 | 126 | 2 | cv:C5779784 | |
| Disease | Malignant hyperpyrexia due to anesthesia | 1.81e-05 | 2 | 126 | 2 | C0024591 | |
| Disease | thyroxine measurement | 2.92e-05 | 83 | 126 | 5 | EFO_0005130 | |
| Disease | hormone measurement | 3.09e-05 | 84 | 126 | 5 | EFO_0004730 | |
| Disease | malignant hyperthermia (is_implicated_in) | 5.41e-05 | 3 | 126 | 2 | DOID:8545 (is_implicated_in) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 5.41e-05 | 3 | 126 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | apolipoprotein A 1 measurement | PDE3B ACACB ADCY5 SNX13 CELF1 ZPR1 YLPM1 LRP1 HERC1 BANK1 CDH16 LRRFIP1 HDLBP | 7.17e-05 | 848 | 126 | 13 | EFO_0004614 |
| Disease | epilepsy (implicated_via_orthology) | 7.39e-05 | 163 | 126 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.08e-04 | 4 | 126 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Rare disease with malignant hyperthermia | 1.08e-04 | 4 | 126 | 2 | cv:C5681128 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 1.79e-04 | 5 | 126 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Congenital muscular hypertrophy-cerebral syndrome | 1.79e-04 | 5 | 126 | 2 | C1802395 | |
| Disease | Cornelia de Lange Syndrome 3 | 1.79e-04 | 5 | 126 | 2 | C1853099 | |
| Disease | Cornelia de Lange Syndrome 1 | 1.79e-04 | 5 | 126 | 2 | C4551851 | |
| Disease | free androgen index | 2.12e-04 | 374 | 126 | 8 | EFO_0007005 | |
| Disease | pappalysinâ1 measurement | 2.56e-04 | 29 | 126 | 3 | EFO_0010618 | |
| Disease | De Lange syndrome | 2.68e-04 | 6 | 126 | 2 | cv:C0270972 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 2.68e-04 | 6 | 126 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | vitamin B12 measurement | 3.44e-04 | 32 | 126 | 3 | EFO_0004620 | |
| Disease | erythronate measurement | 3.75e-04 | 7 | 126 | 2 | EFO_0021025 | |
| Disease | platelet component distribution width | SCN11A MYO9B SEPTIN9 DOCK10 PSMD2 ADCY5 CKB ZPR1 DDHD1 SEPTIN11 HERC1 | 4.05e-04 | 755 | 126 | 11 | EFO_0007984 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 4.32e-04 | 147 | 126 | 5 | DOID:9352 (biomarker_via_orthology) | |
| Disease | mean platelet volume | MYO9B DOCK10 PSMD2 SEPTIN6 SNX13 CELF2 ZPR1 DDHD1 CKAP2L SRRM3 TASOR BANK1 LRRFIP1 | 4.33e-04 | 1020 | 126 | 13 | EFO_0004584 |
| Disease | Cornelia De Lange Syndrome | 4.98e-04 | 8 | 126 | 2 | C0270972 | |
| Disease | serum gamma-glutamyl transferase measurement | UGT1A10 UGT1A8 SEPTIN9 UGT1A7 ICA1 UGT1A9 USP16 RYR2 CELF1 CELF2 DNMBP HDLBP | 5.59e-04 | 914 | 126 | 12 | EFO_0004532 |
| Disease | cholelithiasis | 5.60e-04 | 88 | 126 | 4 | EFO_0004799 | |
| Disease | apolipoprotein B measurement | PDE3B ACACB UGT1A10 UGT1A8 UGT1A7 UGT1A9 PPP4R4 ZPR1 SRRM3 HDLBP | 5.72e-04 | 663 | 126 | 10 | EFO_0004615 |
| Disease | vitamin D measurement | 6.19e-04 | 336 | 126 | 7 | EFO_0004631 | |
| Disease | multisite chronic pain | 7.48e-04 | 95 | 126 | 4 | EFO_0010100 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 7.96e-04 | 10 | 126 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 7.96e-04 | 10 | 126 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | cardiovascular disease | 7.96e-04 | 457 | 126 | 8 | EFO_0000319 | |
| Disease | testosterone measurement | CACNA1D MYO9B UGT1A10 UGT1A8 SEPTIN9 UGT1A7 IQSEC2 UGT1A9 XDH ADCY9 FBXO38 DNMBP BANK1 DNPEP | 1.12e-03 | 1275 | 126 | 14 | EFO_0004908 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.16e-03 | 12 | 126 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | dodecanedioate measurement | 1.16e-03 | 12 | 126 | 2 | EFO_0021054 | |
| Disease | Congenital myopathy (disorder) | 1.16e-03 | 12 | 126 | 2 | C0270960 | |
| Disease | gallstones | 1.21e-03 | 108 | 126 | 4 | EFO_0004210 | |
| Disease | total cholesterol measurement, triglyceride measurement, low density lipoprotein cholesterol measurement, high density lipoprotein cholesterol measurement | 1.21e-03 | 49 | 126 | 3 | EFO_0004530, EFO_0004574, EFO_0004611, EFO_0004612 | |
| Disease | Schizophrenia | SLC25A27 MYO9B ITIH3 CKB JARID2 PTPN1 CELF2 LRP1 SEPTIN11 KCNQ3 RIMS2 | 1.45e-03 | 883 | 126 | 11 | C0036341 |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.53e-03 | 195 | 126 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | monocyte count | DOCK10 PSMD2 ADCY5 PREX2 ADCY9 RYR1 PTPN1 PTGR1 ZPR1 WASF2 ITSN2 YLPM1 SLC25A44 SERPIND1 | 1.55e-03 | 1320 | 126 | 14 | EFO_0005091 |
| Disease | memory performance | 1.92e-03 | 409 | 126 | 7 | EFO_0004874 | |
| Disease | nervousness | 2.09e-03 | 16 | 126 | 2 | NCIT_C74532 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.18e-03 | 60 | 126 | 3 | EFO_0022233 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLRVQLEKMFEAMGG | 1261 | Q9UPW8 | |
| MGKSGLEMIQQEKLR | 706 | Q8NDB2 | |
| ENGKTIQFGEEMMKR | 56 | Q8N5Z0 | |
| IQAMNGFQIGMKRLK | 481 | O95319 | |
| MLGKQQTDEDVRKMF | 101 | Q5SZQ8 | |
| MNGFQIGMKRLKVQL | 441 | Q5SZQ8 | |
| MTFKGFQMNEEKLEI | 1 | Q8IX95 | |
| QQRGKIKATDLMVAM | 66 | Q96GE6 | |
| MQVAMNGKARKEAVQ | 11 | Q9ULA0 | |
| GTVSRIKMQEGVKMA | 181 | Q9H5V8 | |
| SMNGFQIGMKRLKVQ | 461 | Q92879 | |
| EDRRMQGEKGMQGEK | 896 | Q96L96 | |
| GLFGNMQMVIKVSKQ | 826 | Q6XZF7 | |
| GNQVSKEMKRMGFED | 686 | O95622 | |
| AKQGQMDAVRIMAKD | 51 | O43633 | |
| AMNGFQIGMKRLKVQ | 456 | Q96J87 | |
| QEKMGIMNKGVIYAL | 1051 | Q13625 | |
| EFKKEQGKLMGMNEI | 981 | Q13367 | |
| AQAGEVVLKMKVEGM | 166 | Q04656 | |
| MSGQRVDVKVVMLGK | 1 | Q969Q5 | |
| GFTVKAMMKNSVVRG | 41 | Q96M98 | |
| QGKDVLMNNGLKMDQ | 131 | P57729 | |
| GMENVQEKSKEGMID | 176 | Q9NRW1 | |
| KMLMNIEKVQIHFGG | 1501 | Q9H0J4 | |
| DGKMDQQEFSIAMKL | 71 | Q9NZM3 | |
| KMCGVGEQMRKKQQR | 1181 | Q14573 | |
| NEREVVKVSMMQTKG | 316 | P05546 | |
| NEVGMVAFKMRFKTQ | 1766 | O00763 | |
| NEDMIPTVGFNMRKI | 46 | Q96BM9 | |
| GDAQKLEVENVMMRK | 1736 | Q5JPF3 | |
| KVLELQMNKRGFSME | 306 | Q9Y5S8 | |
| GVVMLNRVMEKGSLK | 106 | P18031 | |
| KQKGRMLGDVLMDQN | 171 | Q8TAT5 | |
| KQELMSMKEVGDGLQ | 16 | Q9NTI7 | |
| RVISMQKGGNMKEVF | 236 | P12277 | |
| DNTVMFMQGKRQKEI | 636 | O15111 | |
| QMKGENRKTLISGMI | 3986 | Q07954 | |
| VESELEKQKGMMRPN | 1091 | Q5JU85 | |
| QSMMGKFVKVERQVQ | 616 | O43525 | |
| MVRSIGKTMVQGKNY | 4456 | Q15751 | |
| TAGMIGVQEMRDAFK | 101 | Q9NP86 | |
| EQGSQRGEKMKGKMV | 881 | Q5VYM1 | |
| EKMGEKSGRILSQVM | 686 | Q13370 | |
| EKIASQMITEGRMNG | 336 | Q9BT78 | |
| DGNVTQETKKMEMKG | 966 | Q6KC79 | |
| VGRQMVTGLMTKAEK | 376 | Q7L4E1 | |
| VRNTISGMQKFMGED | 136 | Q9H4K1 | |
| IQVGMMDKKGQLEVE | 1261 | Q9UQ26 | |
| IDFAEMKQMNLTTGK | 86 | Q9NR21 | |
| GEEISEMRQMKKGVF | 1151 | Q6PIJ6 | |
| EMRQMKKGVFQRVVA | 1156 | Q6PIJ6 | |
| LVQFGVMIEKMTGKS | 21 | Q9NZK7 | |
| ESANKFGMKDMRVQT | 346 | O75419 | |
| NIKEEGAMKEDSGMQ | 1786 | Q96BY6 | |
| DEVQKMRMAVIGGAI | 111 | O95832 | |
| MQMFGKIALVDGTQI | 1286 | Q13698 | |
| MNGFQIGMKRLKVQL | 461 | Q8N6W0 | |
| FCQEKKEMVNMRVGV | 476 | O60503 | |
| KDLMKVLQGVNGEMV | 1016 | Q9H583 | |
| GQKMDQGRIIKNTAM | 416 | Q8NEL9 | |
| MKMRGQAFVIFKELG | 46 | P08579 | |
| MGIFGDEDVKQILKM | 1851 | P21817 | |
| VNGTIGKQMVDMLVE | 3991 | Q92736 | |
| MGKQNSKLRPEVMQD | 1 | P61601 | |
| SYGRDQKGMMKELQT | 201 | O43933 | |
| VIGMQMFGKVAMRDN | 1366 | Q01668 | |
| VEGQCMRKVGRMKGM | 766 | O75309 | |
| ISMEKGGNMKRVFER | 271 | P12532 | |
| IQDVEGKYMQGLKEM | 146 | Q32MZ4 | |
| RLKEGDTMMGQQVAK | 56 | Q14914 | |
| LINEMGGMQQVTDLK | 661 | Q92833 | |
| VISMEKGGNMKRVFE | 271 | P17540 | |
| QGFQDKTRAGKMMQA | 101 | Q05084 | |
| GSENKDKVMEVKGQM | 396 | P33402 | |
| VVLKMQFLDEMKGQG | 656 | Q9NZ71 | |
| EEYEGNMTGKMKLRN | 156 | P59544 | |
| MGKMSERLGQDIKQS | 736 | Q9Y5W8 | |
| KMEDVIARMQDEKNG | 26 | P49802 | |
| QKVGTFRQMLMEKEG | 86 | A6NNA2 | |
| SFTGKQGEMREMQQL | 1101 | Q9UQE7 | |
| DTGEKMNVIGRMSFQ | 81 | Q96NB2 | |
| KQQNDGRPMSDKMFE | 716 | Q6NUP7 | |
| LGELQKKEEEMRQMF | 331 | Q9NVA2 | |
| RVISMEKGGNMKEVF | 236 | P06732 | |
| KFKVFGGMNEENMTE | 86 | Q9UL63 | |
| KDVVVQKQMAFMLGR | 286 | Q13200 | |
| VKSMEDKGMTNINDG | 351 | Q06033 | |
| KAMKQGFEFNIMVVG | 291 | Q9UHD8 | |
| GMDKMIQDGKGDVTI | 56 | P50991 | |
| TVKALAGMQKEMEQD | 306 | Q8TF30 | |
| AGMQKEMEQDAKRFG | 311 | Q8TF30 | |
| HLMMQRKGEKMGRFQ | 136 | Q96H78 | |
| SIMMQVLDKGRFQKP | 66 | Q15198 | |
| FLGELQKKEEEMRQM | 331 | Q14141 | |
| QEEEMNGTKMKFGKR | 641 | Q9UK61 | |
| EIKLKMNSRVVGGIM | 506 | Q14246 | |
| MNSRVVGGIMTGEKK | 511 | Q14246 | |
| AMNGFQIGMKRLKVQ | 461 | Q9BZC1 | |
| RINGMPEVQDMKFIT | 671 | Q8IYA6 | |
| EFSQKMDQIIEGNMK | 386 | O75312 | |
| GRMVAGKVLMAKQEI | 186 | Q86W11 | |
| FGDQMDNAKRMETKG | 391 | Q9HAW8 | |
| MSQFLNEMQETKKGV | 261 | Q9Y5T5 | |
| VQLEKMFESMGGKEL | 1806 | Q8NB66 | |
| MGQKVTGGIKTVDMR | 1 | Q96BD6 | |
| VMEKAQKMNDTIFGF | 361 | P20061 | |
| VKVQMQMEGKRKLEG | 151 | O95847 | |
| GKKNMLVGEVMEFLA | 981 | Q6P2S7 | |
| QGAQKGIRIMEMLLK | 166 | Q8N945 | |
| VQRGNMEKAIDMFNK | 556 | O94826 | |
| NTEIGIEMKFKNMLF | 261 | P47989 | |
| EMAGMEVGKKIFAIN | 626 | Q70Z35 | |
| RVQLEKMFEAMGGKE | 1181 | O14795 | |
| FGDQMDNAKRMETKG | 391 | O60656 | |
| MAYRGQGQKVQKVMV | 1 | P62304 | |
| VMQSGTQMIKLKRGT | 21 | Q4KWH8 | |
| EQLQKMKDFGSEPQM | 1471 | P49750 | |
| MKMGQEFVESKEKLG | 206 | Q9Y6W5 | |
| GKNRMDVMNVEKLFV | 671 | Q9BY31 | |
| QKRFLMNTEMEEGKD | 411 | Q8TCN5 | |
| MQGKNVTVFTVFDKM | 491 | Q49AG3 | |
| RIQLSGMYNVRKGKM | 536 | O60346 | |
| FTKRVMGQDVRMEKV | 1581 | Q01118 | |
| KYMMKVTKGDQGDQN | 1746 | Q9UI33 | |
| VEMMNEKNLEKGLGV | 106 | Q969S3 | |
| KGSGIRKMMDEFEVN | 991 | Q00341 | |
| GIVGALMEVMQKRSK | 466 | O00401 | |
| PQLGMQKEMEQDVKR | 36 | Q1A5X7 | |
| EKLFGVNKDRMSMDQ | 1246 | O60293 | |
| KMNIFGGFRQMVKEG | 231 | Q6NUK1 | |
| RGMDIKQMKNFVSQE | 316 | Q9H267 | |
| FGDQMDNAKRMETKG | 391 | Q9HAW7 | |
| FGDQMDNAKRMETKG | 391 | Q9HAW9 | |
| QAMEMVGFLPATKKQ | 386 | Q13459 | |
| DLENEIKGKGMQVSM | 526 | O76041 |